Raloxifene Hydrochloride Tablet, Coated
Product Images NDC 50090-6177

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 50090-6177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906177)

This product is a medication that contains 60mg of Haloxifen Hydrochloride and is sold in a container with 90 tablets. The recommended storage temperature for this medication is between 68-70°F.*

FDA Label Image

Raloxifene-spl-figure-1 (Raloxifene Spl Figure 1)

Total hip mean percentage change from baseline is reported for placebo and Raloxifene Hydrochloride subjects from two studies, NA and EUS, over a duration of 24 months. The same measure is also reported for placebo, Raloxifene Hydrochloride, and CE subjects from Study INT, but this study only included hysterectomized women. The text also mentions something about "Biptene Hysrochorive" and "Weatanass," but it is not clear what they refer to.*

FDA Label Image

Raloxifene-spl-strc.jpg (Raloxifene Spl Strc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.